Savara Pharmaceuticals Company
Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection in cystic fibrosis.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Austin, Texas, United States
Founded Date:
2007
Estimated Revenue:
$10M to $50M
Register and Claim Ownership